Pacira Pharmaceuticals acquires med device company MyoScience in deal worth up to $220M
Dubbed iovera, MyoScience's technology received FDA clearance in 2017 for treating the pain associated with osteoarthritis after knee replacement surgery.
Dubbed iovera, MyoScience's technology received FDA clearance in 2017 for treating the pain associated with osteoarthritis after knee replacement surgery.